Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rubin

Showing results (1051-1060 of 1,202) with videos related to

Pageof 121
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: preliminary evidence of clinical activityA A Adjei, C E Klein, H Kastrissios, et al.
The American Journal of Cardiology|August 3, 2012
Safety and efficacy of transition from systemic prostanoids to inhaled treprostinil in pulmonary arterial hypertensionVinicio A de Jesus Perez, Erica Rosenzweig, Lewis J Rubin, et al.
Arthritis and Rheumatism|June 3, 2008
Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: a Delphi consensus study with cluster analysisOliver Distler, Frank Behrens, David Pittrow, et al.
Annals of Neurology|February 5, 1998
Compound heterozygous genotype is associated with protracted juvenile neuronal ceroid lipofuscinosisK E Wisniewski, N Zhong, W Kaczmarski, et al.
Annals of Internal Medicine|October 22, 2008
Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trialGérald Simonneau, Lewis J Rubin, Nazzareno Galiè, et al.
Nature Communications|April 5, 2020
Pyrazinamide triggers degradation of its target aspartate decarboxylasePooja Gopal, Jickky Palmae Sarathy, Michelle Yee, et al.
Journal of the American College of Cardiology|December 21, 2013
New trial designs and potential therapies for pulmonary artery hypertensionMardi Gomberg-Maitland, Todd M Bull, Rajeev Saggar, et al.
Journal of the American College of Cardiology|October 19, 2006
Favorable effects of inhaled treprostinil in severe pulmonary hypertension: results from randomized controlled pilot studiesRobert Voswinckel, Beate Enke, Frank Reichenberger, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|February 21, 2015
[New trial designs and potential therapies for pulmonary artery hypertension]Mardi Gomberg-Maitland, Todd M Bull, Rajeev Saggar, et al.
Nature Microbiology|February 7, 2017
Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platformJeremy M Rock, Forrest F Hopkins, Alejandro Chavez, et al.
Pageof 121

Showing results (1051-1060 of 1,202) with videos related to

Sort By:
Pageof 121
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Phase I and pharmacokinetic study of irinotecan and docetaxel in patients with advanced solid tumors: preliminary evidence of clinical activityA A Adjei, C E Klein, H Kastrissios, et al.
The American Journal of Cardiology|August 3, 2012
Safety and efficacy of transition from systemic prostanoids to inhaled treprostinil in pulmonary arterial hypertensionVinicio A de Jesus Perez, Erica Rosenzweig, Lewis J Rubin, et al.
Arthritis and Rheumatism|June 3, 2008
Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: a Delphi consensus study with cluster analysisOliver Distler, Frank Behrens, David Pittrow, et al.
Annals of Neurology|February 5, 1998
Compound heterozygous genotype is associated with protracted juvenile neuronal ceroid lipofuscinosisK E Wisniewski, N Zhong, W Kaczmarski, et al.
Annals of Internal Medicine|October 22, 2008
Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trialGérald Simonneau, Lewis J Rubin, Nazzareno Galiè, et al.
Nature Communications|April 5, 2020
Pyrazinamide triggers degradation of its target aspartate decarboxylasePooja Gopal, Jickky Palmae Sarathy, Michelle Yee, et al.
Journal of the American College of Cardiology|December 21, 2013
New trial designs and potential therapies for pulmonary artery hypertensionMardi Gomberg-Maitland, Todd M Bull, Rajeev Saggar, et al.
Journal of the American College of Cardiology|October 19, 2006
Favorable effects of inhaled treprostinil in severe pulmonary hypertension: results from randomized controlled pilot studiesRobert Voswinckel, Beate Enke, Frank Reichenberger, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|February 21, 2015
[New trial designs and potential therapies for pulmonary artery hypertension]Mardi Gomberg-Maitland, Todd M Bull, Rajeev Saggar, et al.
Nature Microbiology|February 7, 2017
Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platformJeremy M Rock, Forrest F Hopkins, Alejandro Chavez, et al.
Pageof 121